Melanoma, Skin cancer
Results
Phase 3
This trial compared dabrafenib and trametinib with vemurafenib to treat melanoma that had spread to another part of the body. The trial was for people:
who hadn’t had treatment for advanced melanoma
whose melanoma cells had a change in a gene called BRAF
Recruitment start: 1 June 2012
Recruitment end: 6 June 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Lorigan
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 15 Sept 2016
CRUK internal database number: 9864
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
